Form 4: Aspira Women's Health Director, John Phillip Ragard, Acquires Restricted Stock Units

Director John Phillip Ragard acquired 19,375 restricted stock units in Aspira Women's Health Inc.

Summary

• On August 22, 2024, John Phillip Ragard, a director of Aspira Women's Health Inc., acquired 19,375 restricted stock units.
• These restricted stock units represent a contingent right to receive one share of Aspira Women's Health Inc.'s common stock each.
• The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025, and the date of the annual shareholders' meeting, contingent upon continued service to the Issuer through the applicable vesting dates.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and aligns director interests with shareholders.

Positives

• The acquisition of restricted stock units by a director signals confidence in the company's future.

Future Outlook

The vesting schedule indicates a long-term commitment from the director to the company's success.

Industry Context

This type of equity compensation is common for directors and executives to align their interests with those of shareholders.

Stakeholder Impact

• Shareholders may view this as a positive sign, indicating that a key director is incentivized to contribute to the company's long-term success.

Key Dates

Keywords

Aspira Women's Health, Restricted Stock Units, Director, Acquisition, AWH, Form 4, Ragard